The Policy Dialogue was hosted in Trieste on April 18-19, 2024 by the WHO European Regional Office, the Central European Initiative, and the European Observatory on Health Systems and Policies. It sought to strengthen pharmaceutical and health product systems by addressing quality assurance and regulatory oversight, shortages,  access to innovative medicines, and financial hardship.

Katrina’s contribution, based on her ongoing research exploring the EU’s role in global access to medicine, discussed the implications of the EU’s revised pharmaceutical

legislation (specifically data and market exclusivity rules, milestone prizes, and voluntary joint procurement) for the pricing of pharmaceuticals. Katrina’s participation was supported in part by a Veni talent grant from the Netherlands Organisation of Scientific Research and the Amsterdam University Funds.